Alireza Noroozi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alireza Noroozi has a total of 162 co-authors. Here are the top co-authors by number of shared publications:
- Afarin Rahimi-Movaghar
Iranian National Center for Addiction Studies (INCAS) Tehran University of Medical Sciences Tehran Iran
5 shared publications - Hamid Sharifi
HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
5 shared publications Ahmad Hajebi
Psychiatric Department Research Center for Addiction and Risky Behaviors University of Medical Sciences Tehran Iran
4 shared publications- Ahmad Hajebi
Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
3 shared publications - Hamed Ekhtiari
Department of Psychiatry, University of Minnesota, Minneapolis, MN, United States
3 shared publications - Mahboubeh Firouzkouhi Moghaddam
Department of Psychiatry, School of Medicine, Baharan Psychiatric Hospital, Zahedan University of Medical Sciences, Zahedan, Iran
3 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 17, 1933443
Comparative efficacy of naltrexone-accelerated versus sublingual buprenorphine in opioid withdrawal management and initiating injectable naltrexone treatment: study protocol for a randomized controlled trial
Background: Extended-release injectable naltrexone (XR-NTX), a long-acting opioid antagonist, is an effective relapse prevention strategy in the treatment of opioid use disorder (OUD). However, standard XR-NTX initiation requires completion of opioid withdrawal management and a 1–2 week opioid-free period. This interval is associated with heightened vulnerability to lapse and relapse, and many patients fail to initiate XR-NTX treatment successfully. Therefore, alternative strategies that enable rapid XR-NTX initiation are needed. This study aimed to compare the effectiveness and safety of naltrexone-accelerated (NA) versus sublingual buprenorphine (SB) withdrawal management in facilitating XR-NTX initiation among patients with OUD. Methods: This single-center, open-label, randomized controlled trial uses a parallel-group design. Eligible patients aged 18–60 years with moderate to severe OUD who are actively using opioids and are not receiving regular maintenance treatment with methadone or buprenorphine are randomly assigned to one of two groups: (1) NA withdrawal management, comprising one day of adjunctive non-opioid medications, one day of buprenorphine administration, one day of washout, and four days of gradual oral naltrexone titration (1, 3, 12, and 25 mg/day); or (2) SB withdrawal management, comprising one day of adjunctive non-opioid medications, six days of buprenorphine tapering (up to 8 mg on Day 2, 6 mg on Day 3, 4 mg on Days 4–5, 2 mg on Day 6, and 1 mg on Day 7), and a seven-day washout period. Adjunctive non-opioid medications in both groups comprised clonidine, clonazepam, gabapentin, and trazodone. The primary outcomes are the proportions of participants who (1) achieve a negative urine drug test for the assessed opioids and (2) receive XR-NTX at the end of the withdrawal management period. Secondary outcomes include severity of withdrawal symptoms, opioid craving intensity, and adverse effects. All analyses are conducted according to the intention-to-treat principle. Discussion: The findings of this trial may provide clinically relevant evidence to support rapid initiation of XR-NTX treatment in patients with OUD and inform clinical practice. Clinical trial registration: https://en.irct.ir/trial/81525 , Iranian Registry of Clinical Trials IRCT20250123064499N1.
- 7 October 2026
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 17, 1933443
Open AccessComparative efficacy of naltrexone-accelerated versus sublingual buprenorphine in opioid withdrawal management and initiating injectable naltrexone treatment: study protocol for a randomized controlled trial
Background: Extended-release injectable naltrexone (XR-NTX), a long-acting opioid antagonist, is an effective relapse prevention strategy in the treatment of opioid use disorder (OUD). However, standard XR-NTX initiation requires completion of opioid withdrawal management and a 1–2 week opioid-free period. This interval is associated with heightened vulnerability to lapse and relapse, and many patients fail to initiate XR-NTX treatment successfully. Therefore, alternative strategies that enable rapid XR-NTX initiation are needed. This study aimed to compare the effectiveness and safety of naltrexone-accelerated (NA) versus sublingual buprenorphine (SB) withdrawal management in facilitating XR-NTX initiation among patients with OUD. Methods: This single-center, open-label, randomized controlled trial uses a parallel-group design. Eligible patients aged 18–60 years with moderate to severe OUD who are actively using opioids and are not receiving regular maintenance treatment with methadone or buprenorphine are randomly assigned to one of two groups: (1) NA withdrawal management, comprising one day of adjunctive non-opioid medications, one day of buprenorphine administration, one day of washout, and four days of gradual oral naltrexone titration (1, 3, 12, and 25 mg/day); or (2) SB withdrawal management, comprising one day of adjunctive non-opioid medications, six days of buprenorphine tapering (up to 8 mg on Day 2, 6 mg on Day 3, 4 mg on Days 4–5, 2 mg on Day 6, and 1 mg on Day 7), and a seven-day washout period. Adjunctive non-opioid medications in both groups comprised clonidine, clonazepam, gabapentin, and trazodone. The primary outcomes are the proportions of participants who (1) achieve a negative urine drug test for the assessed opioids and (2) receive XR-NTX at the end of the withdrawal management period. Secondary outcomes include severity of withdrawal symptoms, opioid craving intensity, and adverse effects. All analyses are conducted according to the intention-to-treat principle. Discussion: The findings of this trial may provide clinically relevant evidence to support rapid initiation of XR-NTX treatment in patients with OUD and inform clinical practice. Clinical trial registration: https://en.irct.ir/trial/81525 , Iranian Registry of Clinical Trials IRCT20250123064499N1.
- 6 July 2026
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 61 (13) , 2312-2319
Outcomes of Methadone and Buprenorphine Maintenance Treatments in Opioid Use Disorder Patients: A Retrospective Cohort Study
Opioid use disorder (OUD) is a chronic and long-lasting condition that presents one of the most critical health issues. It can lead to physical and mental health consequences for individuals, famil...
- 6 July 2026
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 61 (13) , 2312-2319
Outcomes of Methadone and Buprenorphine Maintenance Treatments in Opioid Use Disorder Patients: A Retrospective Cohort Study
Opioid use disorder (OUD) is a chronic and long-lasting condition that presents one of the most critical health issues. It can lead to physical and mental health consequences for individuals, famil...
- Open Access
- 13 July 2024
- Published by Brieflands in Iranian Journal of Psychiatry and Behavioral Sciences
- Vol. 18 (3)
Cognitive Impairments and Its Related Factors in People Who Injects Drugs in Iran
Background: One of the most common psychological problems among people who use drugs (PWUD) is cognitive impairments (CIs). Several studies show that the prevalence of cognitive impairments in PWUD is higher than in the general population. Objectives: The aim of the current study was to investigate the prevalence of CI and its related factors among people who inject drugs (PWID) in Iran. Methods: A cross-sectional study was designed among PWID in 2023. About 410 PWID were recruited using snowball and convenience sampling in four provinces in Iran. Demographic and clinical data, as well as the status of cognitive impairments, were collected using bio-behavioral and Montreal Cognitive Assessment questionnaires, respectively. We examined the relationship between all independent variables and CIs status using bivariate logistic regression. Results: The prevalence of CI among participants was 28% (95% confidence interval (CI): 22% - 32%). Behaviors associated with an increased risk of CIs included the length of injecting drug use [adjusted odds ratios (aOR) = 2.7, P = 0.01], methamphetamine use (aOR = 2.8, P < 0.05), and alcohol use (aOR = 2.8, P < 0.05). Conclusions: Methamphetamine and alcohol use were identified as the main predictors of cognitive impairments among PWID. It also seems necessary to consider new interventions in harm reduction programs to address cognitive impairments.
- 13 July 2024
- Published by Brieflands in Iranian Journal of Psychiatry and Behavioral Sciences
- Vol. 18 (3)
Open AccessCognitive Impairments and Its Related Factors in People Who Injects Drugs in Iran
Background: One of the most common psychological problems among people who use drugs (PWUD) is cognitive impairments (CIs). Several studies show that the prevalence of cognitive impairments in PWUD is higher than in the general population. Objectives: The aim of the current study was to investigate the prevalence of CI and its related factors among people who inject drugs (PWID) in Iran. Methods: A cross-sectional study was designed among PWID in 2023. About 410 PWID were recruited using snowball and convenience sampling in four provinces in Iran. Demographic and clinical data, as well as the status of cognitive impairments, were collected using bio-behavioral and Montreal Cognitive Assessment questionnaires, respectively. We examined the relationship between all independent variables and CIs status using bivariate logistic regression. Results: The prevalence of CI among participants was 28% (95% confidence interval (CI): 22% - 32%). Behaviors associated with an increased risk of CIs included the length of injecting drug use [adjusted odds ratios (aOR) = 2.7, P = 0.01], methamphetamine use (aOR = 2.8, P < 0.05), and alcohol use (aOR = 2.8, P < 0.05). Conclusions: Methamphetamine and alcohol use were identified as the main predictors of cognitive impairments among PWID. It also seems necessary to consider new interventions in harm reduction programs to address cognitive impairments.
- Open Access
- 1 December 2023
- Published by Apex Publishing in Alborz University Medical Journal
- Vol. 12 (4) , 448-467
The Structure And Psychometric Properties Of the Organizational Structure Assessment Questionnaire For Addiction Harm Reduction Centers
Aim: The present research was conducted with the aim of developing a tool to evaluate the organizational structure of transit centers to reduce addiction harm. Method: This research was created with the qualitative analysis method of the questionnaire, and the psychometric characteristics were investigated with the quantitative method of confirmatory factor ...
- 1 December 2023
- Published by Apex Publishing in Alborz University Medical Journal
- Vol. 12 (4) , 448-467
Open AccessThe Structure And Psychometric Properties Of the Organizational Structure Assessment Questionnaire For Addiction Harm Reduction Centers
Aim: The present research was conducted with the aim of developing a tool to evaluate the organizational structure of transit centers to reduce addiction harm. Method: This research was created with the qualitative analysis method of the questionnaire, and the psychometric characteristics were investigated with the quantitative method of confirmatory factor ...
- Open Access
- 18 July 2023
- Published by Springer Nature in BMC Psychiatry
- Vol. 23 (1) , 1-10
Blended smartphone intervention for patients in opioid maintenance treatment in Iran: protocol for a randomized controlled trial
Background: The pattern of substance use in Iran is characterized by a high prevalence of opioid use and opioid use disorder (OUD). Although opioid maintenance therapy (OMT) has been introduced in Iran, approximately 50% of people with opioid use disorder remain unreached. Moreover, psychosocial treatment of OUD and common mental health symptoms during OMT is limited. Digital interventions have been shown to improve psychological distress, depression, anxiety, and post-traumatic stress disorder symptoms. In addition, providing psychoeducation and risk reduction counseling to prevent communicable diseases like HIV and infectious hepatitis is common via the Internet. However, despite these promising advances, no smartphone intervention in OMT has been investigated for the treatment of OUD and common comorbid mental health symptoms. Objective: We examine the effectiveness of adding a blended smartphone intervention based on community reinforcement approach, motivational interviewing- and cognitive behavioral therapy compared to OMT as usual that aims to improve OMT outcomes and addresses common mental health symptoms in OMT patients in Iran. Method: Adults with opioid dependence entering 8 treatment centers in Tehran, Iran will be randomly assigned to receive either OMT plus a smartphone intervention or OMT as usual. The primary outcomes will be the percentage of negative urine tests for illicit, non-prescribed use of opioids (opium, heroin, tramadol) and treatment retention. Secondary outcomes will include the longest period of abstinence from the illicit, non-prescribed use of opioids (opium, heroin, and tramadol) confirmed by urine samples, changes in communicable disease risk-taking behaviors, changes in stress and common mental health symptoms, and client satisfaction. Data analysis will follow the intention-to-treat principle and employ (generalized) linear mixed models. Discussion: This study will provide substantial knowledge for designing effective blended interventions for OUD. Moreover, it will investigate if treatment retention and OMT-related outcomes and common mental health symptoms can be improved by adding a smartphone intervention to OMT. Trial Registration: https://en.irct.ir/trial/53578.
- 18 July 2023
- Published by Springer Nature in BMC Psychiatry
- Vol. 23 (1) , 1-10
Open AccessBlended smartphone intervention for patients in opioid maintenance treatment in Iran: protocol for a randomized controlled trial
Background: The pattern of substance use in Iran is characterized by a high prevalence of opioid use and opioid use disorder (OUD). Although opioid maintenance therapy (OMT) has been introduced in Iran, approximately 50% of people with opioid use disorder remain unreached. Moreover, psychosocial treatment of OUD and common mental health symptoms during OMT is limited. Digital interventions have been shown to improve psychological distress, depression, anxiety, and post-traumatic stress disorder symptoms. In addition, providing psychoeducation and risk reduction counseling to prevent communicable diseases like HIV and infectious hepatitis is common via the Internet. However, despite these promising advances, no smartphone intervention in OMT has been investigated for the treatment of OUD and common comorbid mental health symptoms. Objective: We examine the effectiveness of adding a blended smartphone intervention based on community reinforcement approach, motivational interviewing- and cognitive behavioral therapy compared to OMT as usual that aims to improve OMT outcomes and addresses common mental health symptoms in OMT patients in Iran. Method: Adults with opioid dependence entering 8 treatment centers in Tehran, Iran will be randomly assigned to receive either OMT plus a smartphone intervention or OMT as usual. The primary outcomes will be the percentage of negative urine tests for illicit, non-prescribed use of opioids (opium, heroin, tramadol) and treatment retention. Secondary outcomes will include the longest period of abstinence from the illicit, non-prescribed use of opioids (opium, heroin, and tramadol) confirmed by urine samples, changes in communicable disease risk-taking behaviors, changes in stress and common mental health symptoms, and client satisfaction. Data analysis will follow the intention-to-treat principle and employ (generalized) linear mixed models. Discussion: This study will provide substantial knowledge for designing effective blended interventions for OUD. Moreover, it will investigate if treatment retention and OMT-related outcomes and common mental health symptoms can be improved by adding a smartphone intervention to OMT. Trial Registration: https://en.irct.ir/trial/53578.
- 16 February 2023
- Published by Springer Nature
- p. 1-4
Galactosemia
- 11 November 2022
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 80, 103322
Management of gabapentin misuse in a patient with previous history of opioid use disorder: Case report
- 11 November 2022
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 80, 103322
Management of gabapentin misuse in a patient with previous history of opioid use disorder: Case report
- Open Access
- 21 September 2022
- Published by Brieflands in Iranian Journal of Psychiatry and Behavioral Sciences
- Vol. 16 (3)
Evaluation of a Training Program in General Practitioners’ Attitude Toward the Integration of Substance Use Disorders Services in Primary Health Care
Background: Substance use disorders (SUDs) are associated with high burdens for countries. It has been shown that the integration of SUD services into primary health care (PHC) can improve the early identification and treatment of people with SUDs. However, there are many barriers, including negative attitudes of health professionals about SUDs contributing to suboptimal care. Objectives: This study aimed to investigate the effectiveness of a training program on physicians’ attitudes toward providing SUD services in PHC. Methods: Physicians working in community health centers (CHCs) of Khorasan-e-Razavi Province in Iran were purposefully recruited to participate in a 10-hour in-person training program providing education on understanding the nature of SUDs, basic communication skills, motivational interviewing, and evidence-based SUDs interventions between October and December 2018. Knowledge and attitudes of participants were measured before and after training workshops. Results: The knowledge of physicians was significantly increased after completion of training. Moreover, participants’ attitudes toward the integration of SUD services into PHC significantly improved from 96.23 ± 0.90 to 109.22 ± 0.60 at the end of the workshop. In the multivariable linear regression, previous SUDs’ training experiences, being female, and years of work experience in PHC were significantly associated with more favorable attitudinal changes among the participants. Conclusions: Our results suggest the effectiveness of the training intervention in improving the attitudes toward SUD services among PHC physicians in Iran. Further controlled studies are needed to investigate the effectiveness of training on the attitudes of PHC professionals in the long term and its role in their practice.
- 21 September 2022
- Published by Brieflands in Iranian Journal of Psychiatry and Behavioral Sciences
- Vol. 16 (3)
Open AccessEvaluation of a Training Program in General Practitioners’ Attitude Toward the Integration of Substance Use Disorders Services in Primary Health Care
Background: Substance use disorders (SUDs) are associated with high burdens for countries. It has been shown that the integration of SUD services into primary health care (PHC) can improve the early identification and treatment of people with SUDs. However, there are many barriers, including negative attitudes of health professionals about SUDs contributing to suboptimal care. Objectives: This study aimed to investigate the effectiveness of a training program on physicians’ attitudes toward providing SUD services in PHC. Methods: Physicians working in community health centers (CHCs) of Khorasan-e-Razavi Province in Iran were purposefully recruited to participate in a 10-hour in-person training program providing education on understanding the nature of SUDs, basic communication skills, motivational interviewing, and evidence-based SUDs interventions between October and December 2018. Knowledge and attitudes of participants were measured before and after training workshops. Results: The knowledge of physicians was significantly increased after completion of training. Moreover, participants’ attitudes toward the integration of SUD services into PHC significantly improved from 96.23 ± 0.90 to 109.22 ± 0.60 at the end of the workshop. In the multivariable linear regression, previous SUDs’ training experiences, being female, and years of work experience in PHC were significantly associated with more favorable attitudinal changes among the participants. Conclusions: Our results suggest the effectiveness of the training intervention in improving the attitudes toward SUD services among PHC physicians in Iran. Further controlled studies are needed to investigate the effectiveness of training on the attitudes of PHC professionals in the long term and its role in their practice.
- Open Access
- 10 September 2022
- Published by Maad Rayan Publishing Company in International Journal of Health Policy and Management
- Vol. 12 (1)
Population Size Estimation of People Who Use Illicit Drugs and Alcohol in Iran (2015-2016)
Background: Estimating the number of people using illicit drugs and alcohol is necessary for informing health policy and programming. However, it is often challenging to reliably estimate the size of these marginalized populations through direct methods. In this study, we estimated the population size of these groups using the indirect Network Scale-Up (NSU) method in Iran from 2015 to 2016. Methods: Using a self-administered questionnaire, we asked 15 124 individuals (54% men) about the number of people they know who used different types of drugs at least once in the past 12 months. Prevalence estimates were reported per 100 000 population. The uncertainty level (UL) was calculated using the bootstrap method. Results: The average age of the respondents was 33 years old, and 35.1% of them were unmarried. The most common drugs and their prevalence were as follows: opium (2534 [95% UL: 2467-2598]), hashish (849 [95% UL: 811-886]), stimulants (methamphetamine, ecstasy pills, cocaine, and Ritalin) (842 [95% UL: 802-879]), heroin/crack (578 [95% UL: 550-607]), and drug injection (459 [95% UL: 438-484]). Additionally, we estimated the prevalence of alcohol use as 2797 (95% UL: 2731-2861). On average, substance use was 5.23 times more prevalent among men than women. Opium use was more prevalent among individuals aged >50 years old. Moreover, alcohol use was more prevalent among participants between 18 and 30 years old (5164 per 100 000 population). Conclusion: Although opium continues to be the most prevalent illicit drug in Iran, the patterns of illicit drug use are heterogeneous among different age groups, genders, and provinces. Age-gender specific and culturally appropriate interventions are warranted to meet the needs of people in different subgroups.
- 10 September 2022
- Published by Maad Rayan Publishing Company in International Journal of Health Policy and Management
- Vol. 12 (1)
Open AccessPopulation Size Estimation of People Who Use Illicit Drugs and Alcohol in Iran (2015-2016)
Background: Estimating the number of people using illicit drugs and alcohol is necessary for informing health policy and programming. However, it is often challenging to reliably estimate the size of these marginalized populations through direct methods. In this study, we estimated the population size of these groups using the indirect Network Scale-Up (NSU) method in Iran from 2015 to 2016. Methods: Using a self-administered questionnaire, we asked 15 124 individuals (54% men) about the number of people they know who used different types of drugs at least once in the past 12 months. Prevalence estimates were reported per 100 000 population. The uncertainty level (UL) was calculated using the bootstrap method. Results: The average age of the respondents was 33 years old, and 35.1% of them were unmarried. The most common drugs and their prevalence were as follows: opium (2534 [95% UL: 2467-2598]), hashish (849 [95% UL: 811-886]), stimulants (methamphetamine, ecstasy pills, cocaine, and Ritalin) (842 [95% UL: 802-879]), heroin/crack (578 [95% UL: 550-607]), and drug injection (459 [95% UL: 438-484]). Additionally, we estimated the prevalence of alcohol use as 2797 (95% UL: 2731-2861). On average, substance use was 5.23 times more prevalent among men than women. Opium use was more prevalent among individuals aged >50 years old. Moreover, alcohol use was more prevalent among participants between 18 and 30 years old (5164 per 100 000 population). Conclusion: Although opium continues to be the most prevalent illicit drug in Iran, the patterns of illicit drug use are heterogeneous among different age groups, genders, and provinces. Age-gender specific and culturally appropriate interventions are warranted to meet the needs of people in different subgroups.